One in eight American adults have used popular weight loss and diabetes drugs known as GLP-1 agonists, according to the latest KFF Health Tracking Poll.
The survey, which involved nearly 1,500 adult participants and was carried out in late April, found that two-thirds of those currently using the drugs are doing so to manage diabetes or heart disease, while roughly four out of 10 are taking the medication primarily for weight loss.
